BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19153426)

  • 1. Is stenting a preferred option for unprotected left main coronary artery disease in the drug-eluting stent era?
    Park SJ
    Indian Heart J; 2007; 59(2 Suppl B):B105-12. PubMed ID: 19153426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.
    Tanigawa J; Sutaria N; Goktekin O; Di Mario C
    J Interv Cardiol; 2005 Dec; 18(6):455-65. PubMed ID: 16336426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of drug-eluting stents on transferring treatment with coronary surgical revascularization among patients initially admitted to department of internal medicine].
    He LQ; Ma CS; Nie SP; Lü Q; Jia CQ; DU X; Liu XH; Dong JZ; Li ZZ; Chen F; Zhou YJ; Lü SZ; Wu XS
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1518-22. PubMed ID: 17785099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
    Lee MS; Kapoor N; Jamal F; Czer L; Aragon J; Forrester J; Kar S; Dohad S; Kass R; Eigler N; Trento A; Shah PK; Makkar RR
    J Am Coll Cardiol; 2006 Feb; 47(4):864-70. PubMed ID: 16487857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting.
    Mäkikallio TH; Niemelä M; Kervinen K; Jokinen V; Laukkanen J; Ylitalo I; Tulppo MP; Juvonen J; Huikuri HV
    Ann Med; 2008; 40(6):437-43. PubMed ID: 18608116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass surgery or drug eluting stent for unprotected left main coronary artery disease.
    Gupta S; Gupta BM
    J Assoc Physicians India; 2007 Apr; 55():287-91. PubMed ID: 17694790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.
    Biondi-Zoccai GG; Abbate A; Agostoni P; Parisi Q; Turri M; Anselmi M; Vassanelli C; Zardini P; Biasucci LM
    Ital Heart J; 2003 Apr; 4(4):271-80. PubMed ID: 12784781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease.
    Lee MS; Yang T; Dhoot J; Iqbal Z; Liao H
    Am J Cardiol; 2010 Jun; 105(11):1540-4. PubMed ID: 20494658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid coronary revascularization in the era of drug-eluting stents.
    Murphy GJ; Bryan AJ; Angelini GD
    Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years).
    Palmerini T; Barlocco F; Santarelli A; Bacchi-Reggiani L; Savini C; Baldini E; Alessi L; Ruffini M; Di Credico G; Piovaccari G; Di Bartolomeo R; Marzocchi A; Branzi A; De Servi S
    Eur Heart J; 2007 Nov; 28(22):2714-9. PubMed ID: 17901080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.